A sulfated polysaccharide, curdlan sulfate (CRDS) with 1,3-b-D-glucan as a main chain, inhibits HIV-1 infection of human peripheral blood lymphocytes (PBLs) by binding to the V3 region of gp120. We previously showed that T cell (T)-tropic HIV-1 isolates are over 10-fold more sensitive to neutralization by CRDS than macrophage (MT)-tropic viruses, which posseses a relatively less charged amino acid composition in the V3 sequence. To analyze the interaction of CRDS with V3 and its association with neutralization sensitivity of HIV-1 isolates, we examined the effect of CRDS on the binding of neutralizing antibodies to monomeric and oligomeric gp120 mutants of T-and MT-tropic HIV-1 clones in which the V3 loop was either deleted or substituted by V3 of another isolate. Our results showed that the presence and the amino acid composition of the V3 loop appears to determine the extent of interaction of CRDS with the V2 and CD4-binding regions on native gp120 monomers; however, the positive charge of V3 has less effect on this interaction on oligomeric gp120. Furthermore, our results established that only the CRDS-induced masking of V3 on oligomeric gp120 appears to be associated with the anti-HIV-1 activity of CRDS in vitro. Our findings underline the usefulnes of CRDS for understanding the structural constraints on gp120 that drive the transition from MT-to T-tropic isolates in vivo and enable the virus to use multiple fusion cofactors.
INTRODUCTION
amino acids in the V3 loop of gp120 provides a target for negatively charged sulfated polysaccharides (Callahan et A major challenge in the design of therapeutic apal., 1991) and that this binding leads to inhibition of HIVproaches for controlling HIV-1 infection is the biological 1 infection in vitro by interfering with the membrane fusion heterogeneity of the virus itself. Primary HIV-1 isolates process (Callahan et al., 1991; Jagodzinski et al., 1994) . differ in tropism, replicative pattern, cytopathogenicity, Comparative studies of anti-HIV activity of polyanionic sensitivity to soluble CD4, and serum neutralization (Levy, compounds indicated that their effects on conformation 1993). A segment of the viral envelope gene containing of gp120 and the gp120 -CD4 interaction as well as their the V3 region participates in postbinding events that are biological activity may depend upon the chemical strucnecessary for viral entry and infection (Freed et al., 1991) ture of these compounds. For example, among several and has been found to be the principal determinant of sulfated polysaccharides and sulfonic acid dyes which tropism for macrophages . Some auinclude dextran sulfate (DS), CDRS, heparan sulfate, penthors report that the V3 loop alone is sufficient to confer tosan sulfate, sulfated a-and b-cyclodextrin, aurin tricarmacrophage tropism , while others boxylic acid, Evans blue and Chicago sky blue, only aurin maintain that additional segments are required for maxitricarboxylic acid and Evans blue inhibited the CD4 -mum efficiency (Kim et al., 1995; Koito et al., 1995) . It has gp120 binding, whereas the others had only a minimal been suggested that a relatively high number of basic effect on this interaction (Callahan et al., 1991; Jagodzinski et al., 1994; Clanton et al., 1992) . Anti-HIV-1 and anticoagulant activities of DS were found to be largely de-linkage of DS (Jagodzinski et al., 1994) . These observalap the binding site for the CD4 receptor Thali et al., 1991) ; G3-42 and G45-60, mouse mAbs tions, together with the nonantigenicity of CRDS, and its 10-fold lower anticoagulant activity relative to heparin in (MmAbs) directed against epitopes located in the C4 region of gp120 [G3-42 recognizes a core epitope in the guinea pigs and rats (Kaneko et al., 1991) , have led to the initiation of clinical trials of CRDS in HIV-infected C4 region of gp120, but in comparison with F105 HmAb, it is poorly neutralizing and sensitive to amino acid individuals (Gordon et al., 1995) .
Because of the anticipated use of CRDS as a broadly changes in the V3 region (Moore et al., 1993) ]; 0.5b and G3-523, MmAbs directed against a linear epitope located neutralizing agent against a wide variety of HIV-1 isolates, we extended our previous analysis to examine the within the V3 loop (Matsushita et al., 1988) ; 447-52-D, a HmAb that recognizes the top of the V3 loop in a relatively interaction of CRDS with the V2, V3, and CD4-binding domains of monomeric and oligomeric gp120 mutants broad range of HIV-1 isolates (Gorny et al., 1993) ; G3-4, a MmAb that recognizes a discontinuous conformationwith a deletion in the V3 loop of the HTLV-IIIB isolate or with a substitution by V3 of the BaL isolate. Our results dependent epitope in the V2 region (Ho et al., 1991) ; and T11, a MmAb specific for a linear epitope in the C1 region show that interaction of CRDS with the V2 and C4 regions on monomeric gp120 is largely dependent upon the presof gp120 (Earl et al., 1994) . W6/32 is a MmAb specific for the nonpolymorphic determinant of human MHC class ence and the amino acid composition of the V3 region. In contrast, the positive charge of V3 has less effect on I molecules, HSP 72/73 is a MmAb specific for heat shock proteins (HSP) 72/73, and Leu3a (Becton-Dickinson, the interaction of CRDS with C4 or V2 on oligomeric gp120. Furthermore, the degree of reactivity of CRDS with Mountain View, CA) is a MmAb which reacts with an epitope on the CD4 protein located within the NH2-termithe V3 loop on the oligomeric envelope glycoprotein of T-and MT-tropic viruses is associated with neutralization nal domain 1. ). Before HIV-1 infection, cells were stimulated with 1% PHA (Murex DiagnosEnvelope glycoproteins and HIV-1 proviral clones tic Ltd., Darford, England) and maintained in RPMI 1640 culture medium (Gibco BRL, Gaithersburg, MD) conThe HIV-1 (HxB2 substrain of the HTLV-IIIB isolate) envetaining 50 U/ml of rIL-2 (NIH AIDS Research and Referlope glycoproteins of the wild-type (WT) and the DV3 muence Reagent Program, Rockville, MD) as described tant were a generous gift of Dr. J. Sodroski (Dana-Farber (Hwang et al., 1992) . CD4 / T lymphocytes were obtained Cancer Institute). The mutant contains a deletion spanning from PBMC of HIV-1-seronegative donors by cell sorting the V3 loop (amino acids 297-329), with the sequence Glyof Leu3a-positive cells followed by stimulation with 1% Ala-Gly inserted in place of the loop (Wyatt et al., 1992) . Both PHA and irradiated (4000 rads) monocytes. The cells envelope glycoproteins were expressed by transfection of were over 95% positive for CD4 expression and were plasmid pSVIII-env containing either the WT or the mutated maintained in RPMI 1640 medium supplemented with envelope gene into COS-1 cells. rIL-2. Human rhabdomyosarcoma cells (RD-4 cells) and
The HIV-1 recombinant clones pIIIB, pBaL, and pIIIB/ simian COS-1 cells were obtained from Dr. A. Srinivasan V3-BaL were a generous gift from Dr. B. Cullen (Howard (Thomas Jefferson University, Philadelphia, PA) and Dr. J.
Hughes Medical Institute, Duke University Medical CenSodroski (Dana-Farber Cancer Institute, Harvard Medical ter, Durham, NC). The T-tropic HIV-1 clone, pIIIB, contains School, Boston, MA), respectively. Both cell lines were a modified form of the replication-competent HxB3 provimaintained as monolayer cultures in DMEM (Gibco BRL, rus derived from the HTLV-IIIB isolate (Hwang et al., Gaithersburg, MD) . All media were supplemented with 1991). The HxB3 provirus present in the pIIIB plasmid is 10% FCS and antibiotics. similar to the published clone except that the single base pair frame-shift mutation present in the vpr gene of HxB3 Monoclonal antibodies has been repaired . At Ç72 hr after transfection, the COS-1 cultures were fed with fresh meAnti-gp120 mAbs comprised the following: F105, a human mAb (HmAb) directed against an epitope composed dium containing PHA-activated PBMC at a density of 10 6 cells/ml. Cells were cultivated with the transfected COSof four discontinuous regions of gp120 that partially over-1 cells for 3 days, aspirated, washed, and maintained in by p24 antigen production determined by immunocapture assay (Du Pont Company, Wilmington, DE) . Because the expanded culture for 4 more days. On Day 7 after infection, supernatants were removed, filtered through a 0.45-growth rate of IL-2-dependent T lymphocytes is lower at concentrations of CRDS ú50 mg/ml, cells in all cultures mm filter, and virus stocks were stored at 070Њ.
were resuspended to a density of 10 6 cells/ml and superImmunoprecipitation natants were harvested after 24 hr to monitor p24 antigen levels. COS-1 cells were transfected with 10 mg of pSVIIIenv DNA expressing the WT or the DV3 mutant by the DEAEIndirect flow cytometry and blocking assays dextran technique (Cullen, 1987) , whereas RD-4 cells were transfected with 10 mg of the HIV-1 proviral DNA CD4 / T lymphocytes infected for 7 days with 1000 TCID 50 per milliliter of pIIIB, pIIIB/V3-BaL, or pBaL were by the calcium phosphate method (Cullen, 1987) . Immunoprecipitations were carried out 50 -60 hr after transfecincubated for 30 min with anti-gp120 mAbs (1 mg/ml) in PBS buffer containing 2% FCS and 0.1% sodium azide tion using Nonidet P-40 (NP-40) buffer (0.5% NP-40, 0.5 M NaCl, 10 mM Tris -HCl (pH 7.5)) to lyse transfected (PBS/FCS), washed three times in PBS/FCS, stained with a 1:40 dilution of FITC-conjugated F(ab) 2 fragment of cells after overnight labeling with 60 mCi/ml of [ , and fixed by overnight incubation with Boston, MA) in cysteine-and methionine-free DMEM medium. Radiolabeled cell lysates were precipitated with 1% paraformaldehyde. Cells were washed in PBS/FCS and analyzed on a Coulter Cytofluorograf System, PROanti-gp120 mAbs in the presence or absence of 50 mg/ ml of CRDS (molecular mass, 79 { 0.6 kDa, sulfur con-FILE II. For analysis of CRDS-mediated inhibition of binding of anti-gp120 mAbs to oligomeric gp120, pIIIB-, pIIIB/ tent, 15.2 { 0.3%; Ajinomoto Co., Inc., Tokyo, Japan). The cell lysate was divided into aliquots (0.5 ml) and incu-V3-BaL-, and pBaL-infected cells were incubated with F105, G45-60, 447-52-D, and G3-4 mAbs in the presence bated with anti-gp120 mAbs followed by polyclonal rabbit anti-mouse or anti-human antibodies (Organon Teknika or absence of CRDS, followed by FITC-conjugated second antibody and analysis by flow cytometry. Corp., West Chester, PA) and immunocomplexes were precipitated with protein A-Sepharose CL4B (Pharmacia Molecular modeling Biotech, Piscataway, NJ). Samples electrophoresed on a 8% SDS -polyacrylamide gel were analyzed with a storModeled topographical CRDS/gp120 possible associage phosphor imager (PhosphoImager 400S; Molecular ation was performed on a PC computer equipped with Dynamics). The relative amounts of the envelope glycoPentium processor and Number 9 video board using protein were determined from the volume of pixel counts Chem-X for Windows 95 software (Chemical Design Inc., in the envelope bands (Johnston et al., 1990) . The labeled Mahwah, NJ). Energy minimization and molecular dynamcell lysates from transfected COS-1 and RD-4 cells were ics calculation were performed at 301ЊK. coprecipitated with HSP 72/73 and W6/32 mAbs, respecThe CRDS molecule was constructed starting with glutively, to ensure loading of equivalent amounts of protein.
cose, sulfated at the sixth position of carbon. The 6-sulfoglucose was energy optimized in vacuum and dimerized Anti-HIV-1 activity of CRDS by an b-1,3 bond. Then another sulfate group was added at the second position of carbon of the second glucose Virus stocks derived from the indicated HIV-1 recombinant clones were titrated on PHA-induced PBL by the monomer and the structure was optimized by energy minimization in a vaccum. The CRDS unit used for further end-point-dilution method (Dulbecco, 1988) . All stocks were titrated in replicate cultures of PBL derived from a modeling was composed of nine such molecules. This structure was further optimized by energy minimization single donor in flat-bottom wells of 96-well tissue culture plates in RPMI 1640 medium with rIL-2. The median numin conditions simulating the presence of the water solvent. The distance between sulfated groups in each unit ber of tissue culture infectious doses (TCID 50 ) of HIV-1 per milliliter was taken as the inverse of the highest of CRDS was as follows: 6.4 Å is the distance between sulfated groups at the sixth position of carbons of the dilution that resulted in infection of Ç50% of the replicate cultures (Hwang et al., 1992) . To measure anti-HIV-1 acfirst and the second monomers; 11.3 Å is the distance between sulfated groups at the sixth position of carbons tivity of CRDS, virus stocks were diluted to 1000 TCID 50 per milliliter of medium and incubated without or with of the second and the third monomers; 15.8 Å is the distance between sulfated groups at the sixth position 0.1-100 mg/ml CRDS at 37Њ for 30 min before addition to 10 6 PHA-stimulated PBL (Jagodzinski et al., 1994) . Cells of carbons of the first and the third monomers; 20.4 Å is the distance between sulfated groups at the sixth posiwere washed and cultured with or without CRDS in medium containing 50 U/ml of rIL-2. Cells were fed twice a tion of carbons of the first and the fourth monomers.
The secondary structure of the CRDS polymer includes week and virus was sought in the cell-free supernatant sulfate groups that form a well-pronounced edge winding to several regions of envelope glycoproteins, its effect on the neutralizing epitopes of gp120 is largely V3 loopalong the glucose backbone.
The nucleotide sequence of the HxB2 gp120 was obdependent. tained from GenBank (Accession No. M38432), and the Inhibition of T-and MT-tropic HIV-1 recombinant proposed positions of the V2, V3, and C4 structures were clones by CRDS based on models by Gabriel and Mitchell (1993) and Choe and Sodroski (1995) . The molecular modeling of Because the V3 loop of MT-tropic isolates carries the secondary structure of the V2, V3, and CD4-binding lower concentrations of positive charges as compared domains of gp120 was carried out in several identical to T-tropic variants , we studied steps: (i) a randomly coiled structure generated by Chemwhether the V3 loop of BaL confers lower susceptibility X was submitted to geometric energy minimization, with to CRDS neutralization when transferred onto the IIIB constraints limiting the distance between sulfur atoms background ( Fig. 2A) . Analysis of p24 antigen levels in of amino-and carboxyterminal C residues to 5 Å (usually culture supernatants of PHA-induced PBL infected with between 50 and 100 minimization cycles were sufficient pIIIB, pBaL, and pIIIB/V3-BaL viruses after 3, 6, 9, and to bring C residues to the required distance); (ii) a disul-12 days of infection revealed a Ç10-fold reduction in fide bond was formed between these C residues; (iii) sensitivity to CRDS-mediated inhibition of pBaL as comfurther nonconstrained minimization was performed until pared to that of pIIIB: the IC 50 (50% inhibitory concentrareaching the convergence conditions, usually between tion) for CRDS ranged from 20.0 to 29.0 mg/ml for pBaL 300 and 600 cycles; and (iv) molecular dynamics was and 2.1 to 3.5 mg/ml for pIIIB (Fig. 3A) . Complete inhibition performed for 1 psec, followed by energy minimization of infection with pIIIB and pBaL was achieved with CRDS (100 cycles), molecular dynamics for 10 psec, and final at concentrations of 10 and 100 mg/ml, respectively (Figs. energy minimization. Calculations were performed using 3B and 3D). Supernatants collected from CRDS-treated all atom force field algorithm (Weiner et al., 1986) implecultures of pIIIB-infected cells (10 and 100 mg/ml) and mented by Chem-X. pBaL-infected cells (100 mg/ml) at 12 days after infection failed to infect cultures of PHA-induced PBL. The pIIIB/ RESULTS V3-BaL recombinant virus which displayed MT tropism (not shown) was found to be Ç6-fold more resistant to Effect of V3 loop deletion on interaction of CRDS inhibition with CRDS than the pIIIB isolate (Fig. 3C) . The with gp120
IC 50 values for CRDS with pIIIB/V3-BaL ranged from 14.0 To gain insight into the CRDS-induced structural to 18.0 mg/ml, and complete inhibition of infection was changes in the envelope glycoprotein, we first compared observed with 60 mg/ml of CRDS. The similar pattern of the effect of a deletion encompassing the V3 region of susceptibility of pBaL and pIIIB/V3-BaL to inhibition by the HTLV-IIIB isolate on CRDS-mediated inhibition of CRDS suggests that the V3 loop sequence of the BaL binding of gp120-specific mAbs to monomeric gp120 isolate, on a IIIB background, had a profound effect on (monomeric gp120 was derived from COS-1 cell transfecthe resistance of the chimeric virus to CRDS-mediated tants expressing either the WT or DV3 mutant glycoproinhibition. tein). Precipitation of the WT gp120 revealed that the inhibition of binding of anti-V3 loop-specific mAbs G3-Interaction of CRDS with the V2, V3, and C4 domains 523 and 0.5b by CRDS was lower than that of the conforof monomeric and oligomeric gp120 molecules of mation-dependent mAbs G3-42 and F105 directed to the pIIIB, pIIIB/V3-BaL, and pBaL epitopes within the C4 region of gp120 (Table 1 and Fig.  1 ). The effect of CRDS on other domains of gp120 that
The CRDS-mediated inhibition of antibody binding to monomeric gp120 was analyzed by precipitation of RDincluded the V2 loop and the C1 region was small. In the DV3 mutant, a loss of the V3 loop-dependent masking 4 cells transfected with HIV-1 DNA of pIIIB, pIIIB/V3-BaL, and pBaL. The profile of CRDS-mediated inhibition of of the discontinuous epitope recognized by mAb F105 was indicated by the Ç2-fold reduced inhibition of CRDSantibody binding to gp120 of pIIIB (Table 2 , Fig. 4A ) was similar to that of the HxB2 gp120 used for previous studmediated binding of this antibody (Table 1, Fig. 1 ). The observed lack of reactivity with G3-42 might rest in the ies, except that the binding of T11 antibody to the C1 region was slightly increased in the presence of CRDS. sensitivity of this antibody to conformational changes in the C4 region induced by deletion of the V3 region
The CRDS-mediated inhibition of binding mAb 447-52-D to the V3 loop GPGR core epitope was comparable in (Moore et al., 1993) . In contrast, deletion of the V3 loop sequences resulted in an increased exposure of epipIIIB/V3-BaL and pBaL (Figs. 4B and 4C) and Ç2-fold lower than in pIIIB. The inhibition of mAb G45-60 to the topes in V2 and C1 for interaction with CRDS as shown by Ç3-fold higher inhibition of binding of mAbs G3-4 and linear epitope in C4 (Fig. 4D ) was lower in pIIIB/V3-BaL than in pIIIB, and was further decreased in pBaL (Table  T11 . These results suggest that although CRDS can bind 2), despite a good homology of the linear sequences and pBaL was comparable and over threefold lower than in pIIIB-infected cells (Table 2) . However, as opposed to between the C4 region in both HxB2 and BaL (Fig. 2B) . Similar results were obtained with F105 mAb. The epithe results with monomeric gp120, the levels of the CRDS-mediated inhibition of mAb F105 and G45-60 bindtope in the V2 loop of pIIIB/V3-BaL was slightly more accessible to CRDS binding than in the V2 region of pIIIB, ing to their respective epitopes on gp120 oligomers was similar in pIIIB and pIIIB/V3-BaL and Ç20% lower in whereas lack of binding of mAb G3-4 to the V2 loop of pBaL precluded analysis of CRDS-induced conformapBaL. In addition, we did not observe CRDS-mediated inhibition of the binding of mAb G3-4 to the V2 region of tional changes in this region.
The CRDS-mediated inhibition of antibody binding to the pIIIB and pIIIB/V3-BaL oligomeric gp120. Thus, the accessibility of the epitopes recognized by mAbs against the neutralizing domains on oligomeric gp120 molecules was analyzed on CD4 / T lymphocytes infected with 1000 C4 on oligomeric gp120 of pIIIB and pIIIB/V3-BaL was less affected by the differences between interaction of TCID 50 per milliliter of pIIIB, pIIIB/V3-BaL, or pBaL. Using immunofluorescence staining and flow cytometric analy-CRDS with the V3 loop as compared to the native gp120 monomers. These results, together with those of the sis, we observed that the CRDS-induced inhibition of mAb 447-52-D binding to the V3 region in pIIIB/V3-BaL CRDS-induced inhibition of infection by T-and MT-tropic Immunoprecipitates of the WT and DV3 mutant glycoproteins in the presence or absence of CRDS (50 mg/ml) were analyzed on SDSpolyacrylamide gels and the relative intensity of bands representing gp120 was determined by integration of pixel volume corresponding to the amount of radioactivity in the glycoproteins (Johnston et al., 1990) . Percentage inhibition of antibody binding in the presence of CRDS was calculated as 100 1 (1 0 Xa/Xc), where X is the pixel count in gp120 bands immunoprecipitated from COS-1 transfectants in the presence (Xa) or absence (Xc) of CRDS after subtracting background values. Results are presented as mean { SD from three experiments.
b ND, not detected. c Three of the four regions of gp120 are proximal to those previously shown to be important for CD4 binding (Thali et al., 1991) .
FIG. 2.
Restriction enzyme analysis of chimeric HIV-1 clones and predicted amino acid sequences of the V2 and V3 loops and the C4 region of gp120 of HxB2 and BaL. (A) Construction of HIV-1 clones in which BaL sequences (in black) corresponding to the envelope glycoprotein or the V3 loop were substituted onto the pIIIB clone has been described . The nucleotide sequence of the HxB2-and BaL-specific segments are available from GenBank (Accession Nos. M38432 and M68893, respectively). Abbreviations for the restriction enzyme sites are as follows: A, AccI; B, BamHI; D, DraI; K, KpnI; S, SalI; and X, XhoI. (B) The V2, V3, and C4 domain amino acid sequences of HxB2 and BaL envelope glycoproteins used for mAb binding studies were aligned, starting at the amino-terminal cysteine. Amino acid positions are designated with respect to the sequence of HxB2-gp120. Identity of the amino acid sequence in HxB2 and BaL is indicated by dots and deletion by dashes.
isolates, indicate that the V3 loop of oligomeric gp120
The V2 positively charged residues (R166, K168, K171, and K178) are more scattered and, additionally, are interappears to be the major determinant of the neutralization spersed with negatively charged E172 and D180 amino sensitivity of HIV-1 in vitro.
acids. This makes the epitope for the G3-4 antibody V2 region not readily accessible for CRDS. Within the C4 Proposed interaction of CRDS with the V2, V3, and C4 region, three (R419, K421, and R444) of five positively regions of gp120 by molecular modeling charged residues are located very close to the disulfate The automated fitting procedure of Chem-X, used to bridge, which makes them less likely available for interinvestigate the possibility of complex formation between action with CRDS. The remaining K429 and K432 resithe neutralizing domains of gp120 and CRDS, revealed dues that are located near or within the epitope of G45-that the V3 domain represents the most probable site for 60 mAb may not provide sufficient positive charge to the interaction with CRDS (Fig. 5) . The V3 loop with six be solely responsible for the Ç60% of CRDS-mediated positively charged amino acid residues located near and inhibition of binding of the G45-60 mAb. Rather, the obat the top of the loop (R304, K305, R306, R308, R311, served inhibition of antibody binding to this region might and R315) create a positively charged patch which may be due to some unfolding of the gp120 molecule after interact and form a complex with sulfate groups at the interaction of CRDS with V3 which results in masking of the C4 domain. This effect might be further augmented sixth position of carbon in each glucose unit of CRDS. ANTI-HIV-1 ACTIVITY OF SULFATED POLYSACCHARIDES   FIG. 3 . Concentration-dependent neutralization of pIIIB, pIIIB/V3-BaL, and pBaL by CRDS. (A) Activated PBL were exposed to HIV-1 proviral clones for 2 hr at 37Њ in the presence or absence of CRDS, washed, and cultured with CRDS. At 8 days after infection, cells were resuspended to a density of 10 6 cells/ml and culture supernatants were harvested after 24 hr to analyze p24 antigen production. Results are representative of three separate experiments and are means of triplicate values with standard deviation (SD) õ15%. (B-D) Activated PBL were exposed to pIIIB (B), pIIIB/V3-BaL (C), and pBaL (D) for 2 hr at 37Њ in the absence (D) or presence of CRDS: 0.1 mg/ml(X); 0.3 mg/ml (l); 1 mg/ml (ࡗ); 3 mg/ml (᭡); 10 mg/ml ("); 30 mg/ml (᭢), and 100 mg/ml (). Cells were washed and cultured with or without CRDS for 2, 5, 8, and 11 days. Twenty-four hours before the assay, cells were resuspended to a density of 10 6 cells/ml and supernatants were harvested to monitor p24 antigen levels. Results represent means of triplicate values with SD õ 10%.
by the presence of K429 and K432 residues in this region.
V3 loop on the oligomeric envelope glycoprotein was associated with the neutralization sensitivity of the virus. For example, substitution of 429 K/E in gp120 of pBaL resulted in smaller inhibitory effect of CRDS on the bindThis observation is consistent with the results of recent studies which demonstrated structural modulations upon ing of G45-60. gp120 oligomerization determined by differences in the efficiency of mAb binding to dominant neutralizing epi-DISCUSSION topes on oligomeric versus monomeric gp120 molecules In this study, we have analyzed the binding of CRDS (Sattentau and Moore, 1995; Stamatatos and Chengto the V3 and V2 and CD4-binding regions of monomeric Mayer, 1995) . Consequently, the sensitivity of viruses and oligomeric envelope glycoproteins of the WT and V3 containing different envelope glycoproteins to neutralizaloop-deleted or chimeric mutants of the HTVL-IIIB and tion by mAbs, soluble CD4, or sulfated polysaccharides BaL isolates. Our results showed that CRDS effect on could be predicted by assays dependent on the binding monomeric versus oligomeric envelope glycoproteins of the inhibitory molecule to the oligomeric envelope glycoprotein complex but less well by assays measuring differs, and the extent of interaction of CRDS with the binding to the monomeric gp120 glycoprotein (Sattentau effect on virions, the CD4 receptor, and inhibited weakly HIV-1 attachment to cells (Jagodzinski et al., 1994) . Our and Sullivan et al., 1995) .
In view of the complexity of the HIV-1 replicative cycle, recent studies indicate that CRDS does not induce global conformational changes of gp120 but exerts its anti-HIVseveral stages of replication might represent potential targets for anti-HIV-1 therapy. We have shown that CRDS 1 activity through a specific interaction with the V3 loop of gp120. These results may be important in understandexert their anti-HIV-1 activity by interfering with the membrane fusion process during HIV-1 infection but had no ing the interaction of gp120 of T-and MT-tropic isolates , and CD4-binding regions of gp120. The numbering system is as defined in Fig. 2 with V2 in blue, V3 in purple, and C4 in green. CRDS is orange with 1,3-b-D-glucan as a main chain in light green and sulfate groups in yellow. Regions of gp120 between V2, V3, and C4 are shown in gray.
with recently described chemokine receptors during the quence variation in vivo. In Phase I clinical trials, CRDS was found in 4-hr intravenous infusions to be well tolermembrane fusion process. It has been shown that a cofactor for T-tropic HIV-1 isolates is a seven-transmemated up to 200 mg/70 kg. The plasma level of CRDS varied between 20 and 40 mg/ml with CRDS doses rangbrane domain protein, named fusin (Feng et al., 1996) , whereas the fusion cofactors for primary MT-tropic ing from 150 to 200 mg/70 kg (Gordon et al., 1995) . These concentrations of CRDS are quite effective in blocking strains of HIV-1 are receptors for the b-chemokines RANTES, MIP-1a, and MIP-1b (Deng et al., 1996 ; Dragic infection of T-tropic isolates and significantly inhibit infection with MT-tropic strains in vitro. It has been suget al., 1996) . Because the structure of the V3 loop can influence the ability of HIV-1 viruses to respond to the gested that the T-tropic viruses characteristic of disease progression may evolve from MT-tropic viruses prevalent presence of these b-chemokine receptors in the target cells (Choe et al., 1996) , CRDS through its binding to early in virus infection through changes in the envelope protein that enable the virus to use multiple entry cofac-V3 may be useful in understanding the cellular events underlying source of permissiveness for MT-and T-tropic tors (Doranz et al., 1996) . The ''phenotypic switch'' of the HIV-1 virus from MT to T-cell tropism during progression viruses.
The most critical questions concerning CRDS and to AIDS raises the possibility that HIV-1 uses the b-chemokine receptors early in the course of infection and then other polyanionic compounds is their clinical applicability against primary HIV-1 isolates regardless of their selater switches to fusin-like molecules, perhaps by primary HIV-1 isolate that uses fusin and the b-chemokine receptors avoiding the suppressive activity of the chemokines and CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85, 1149-1158. broadening the number of cell types it can attack (Balter, Dragic T., Litwin, V., Allaway, G. P., Martin, S. R., Huang, Y., Nagashima, 1996). Thus, if the appearance of T-tropic isolates contri-K. A., Cayanan, C., Maddon, P. J., Koup, R. A., Moore, J. P., and Paxton, butes to disease progression in vivo, then CRDS might W. A. (1996) . HIV entry into CD4 / cells is mediated by the chemokine prove clinically useful despite its relatively lower effec- type 1 as a fusion domain. J. Virol. 65, 190 -194. Gabriel, J. L., and Mitchell, W. M. (1993) . Proposed atomic structure of a truncated human immunodeficiency virus glycoprotein gp120
